サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1594889

狂犬病診断の世界市場

Rabies Diagnostics

出版日
ページ情報
英文 89 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.08円
狂犬病診断の世界市場
出版日: 2024年11月22日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 89 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

狂犬病診断の世界市場は2030年までに28億米ドルに達する見込み

2023年に19億米ドルと推定される狂犬病診断の世界市場は、2030年には28億米ドルに達し、分析期間2023-2030年のCAGRは5.3%で成長すると予測されます。本レポートで分析したセグメントの1つである蛍光抗体検査（FAT）は、CAGR 5.1％を記録し、分析期間終了時には9億1,010万米ドルに達すると予測されます。免疫組織化学検査分野の成長率は、分析期間中CAGR 5.3%と推定されます。

米国市場は5億1,270万米ドルと推定、中国はCAGR7.8％で成長予測

米国の狂犬病診断市場は、2023年に5億1,270万米ドルと推定されます。世界第2位の経済大国である中国は、2023-2030年のCAGRを7.8%として、2030年までに6億230万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.4%と4.3%と予測されています。欧州では、ドイツがCAGR 3.9%で成長すると予測されています。

狂犬病診断：致命的な疾患のタイムリーな発見と予防の確保

狂犬病診断とは何か、なぜ公衆衛生において重要なのか？

狂犬病診断とは、動物やヒトの狂犬病ウイルスを検出するために使用される方法やツールのことです。狂犬病は症状が現れるとほぼ常に致命的であるが、早期に発見すれば迅速かつ効果的な治療により予防が可能であるため、適時の診断が不可欠です。狂犬病診断は、アウトブレイクの予防、治療方針の決定、ワクチン接種キャンペーンの情報提供など、公衆衛生において重要な役割を果たしています。また、正確な診断法は、獣医師や野生動物の専門家が感染動物を特定する際の助けとなり、人と動物の両方の個体群を守るための管理対策を実施することを可能にします。狂犬病は、感染した動物に噛まれた唾液を介して感染し、中枢神経系を侵し、ほとんどすべての温血動物に広がる可能性があるため、狂犬病の感染を制御し予防するためには、効果的な診断が不可欠です。

咬まれた被害者の曝露の可能性を評価するには、早期かつ正確な狂犬病診断が不可欠です。狂犬病が疑われる場合、診断結果は、症状が発症する前に行われる救命のためのワクチン治療である曝露後予防（PEP）投与の判断に役立ちます。動物、特にコウモリ、アライグマ、キツネ、野良犬などの野生種は狂犬病の主要な保菌者であるため、狂犬病検査は野生動物や家畜の駆除においても極めて重要です。正確な診断により、保健当局はサーベイランスプログラムを実施し、リスクのある地域を特定し、発生率の高い地域に予防努力を集中することができます。これらの措置は、特に狂犬病が依然として流行している地域において、公衆衛生と安全を維持するために極めて重要です。

狂犬病の検出にはどのような診断法が一般的に用いられているか？

狂犬病診断のゴールドスタンダードは直接蛍光抗体（DFA）検査で、これは動物の死後の脳組織を分析するものです。この検査では、狂犬病ウイルス抗原に結合する蛍光標識抗体を使用し、顕微鏡で直接可視化することができます。DFA検査は高感度かつ特異的で、短時間で結果が得られるため、現在でも動物の狂犬病を確認する主要な方法となっています。しかし、脳組織を必要とするため侵襲的であり、動物の死後でなければ実施できないため、その使用事例は死亡または安楽死した動物で疑われる症例に限定されます。

ヒトや非侵襲的な検査が望ましい場合には、他のいくつかの診断法が用いられます。逆転写酵素ポリメラーゼ連鎖反応（RT-PCR）は、唾液、皮膚生検、脳脊髄液などの検体中の狂犬病ウイルスRNAの存在を検出する分子技術です。RT-PCRは生きている患者に対して実施することができるため、死亡前に狂犬病を検出する方法を提供することができるが、DFAよりも感度が低く、特に感染の初期段階では偽陰性を示すことがあります。血液中の狂犬病抗体を検出するには、酵素結合免疫吸着測定法（ELISA）や血清学的検査も用いられるが、これらは通常、活動性感染の診断よりもむしろ、過去に暴露されたことの確認に有用です。これらの方法を組み合わせることで、より包括的な診断アプローチが可能になり、動物とヒトの両方における狂犬病の検出および対応能力が向上します。

狂犬病診断は新しい技術によってどのように進化しているのでしょうか？

狂犬病診断における最近の進歩は、早期発見のためのスピード、アクセス性、非侵襲的な選択肢の改善に重点を置いています。狂犬病の迅速診断検査は、多くの場合ラテラルフローアッセイ技術に基づいており、専門的な検査機器を必要とせず、現場で迅速に検査結果が得られるように開発されています。これらの迅速検査は、獣医師や医療専門家が疑わしい症例を迅速に評価し、必要に応じて隔離やワクチン接種を実施できるため、現場環境において特に有用です。DFA検査ほど正確ではないが、これらの携帯型診断薬は、特に検査施設へのアクセスが制限される農村部や資源の限られた地域において、予備スクリーニングのための貴重なツールとなります。

リアルタイムPCRや次世代シークエンシングを含む分子診断の革新も、狂犬病検出能力を向上させています。リアルタイムPCR技術は、検体中のウイルス量を定量化することができるため、ウイルス量が少ない場合でも高感度で検出することができ、人や動物の早期診断に有益です。さらに、生きている動物の狂犬病を検出するために唾液や涙を使用する非侵襲的診断法の開発研究も進行中であり、これにより、家畜のペットの早期発見が可能になり、疑わしい症例における安楽死の必要性が減少する可能性があります。診断技術の進歩に伴い、よりアクセスしやすく、信頼性が高く、人道的な狂犬病検査法を開発し、多様な環境における疾病管理と予防を改善することが目標です。

狂犬病診断市場の成長を促進する要因は？

狂犬病診断市場の成長は、狂犬病予防に対する意識の高まり、診断技術の進歩、高リスク地域における利用しやすい診断法に対する需要の高まりなどの要因によってもたらされます。狂犬病の危険性と早期診断の重要性に対する認識が高まるにつれ、ヘルスケア当局や獣医組織は、狂犬病の発生を抑制・予防するために狂犬病診断検査を優先するようになっています。さらに、世界の多くの地域で急速な都市化が進み、人間と野生動物との相互作用が増加しているため、狂犬病に感染する可能性が高まり、広範な診断能力の必要性が高まっています。

また、技術の進歩により、携帯可能な迅速検査や分子検査技術が現場や臨床で利用できるようになり、狂犬病診断はより身近なものとなった。これらの技術革新は、特にアフリカ、アジア、ラテンアメリカなど、狂犬病が依然として流行している地域における遠隔地検査の課題に対処するものです。さらに、2030年までに犬を介した狂犬病による人の死亡をなくすという世界保健機関の「Zero by 30」目標のような、狂犬病患者を世界的に減少させるための政府の取り組みや非営利団体との協力が、狂犬病診断の開発と展開を支援する環境を作り出しています。このような複合的な要因が狂犬病診断市場の成長を促し、狂犬病感染を減らし、公衆衛生の成果を向上させる世界の取り組みを支えています。

セグメント

手法（蛍光抗体検査（FAT）、免疫組織化学検査、増幅法、組織学的検査、血清学的検査）;技術（ELISA/免疫組織化学、クロマトグラフィー、PCR、その他の技術）

調査対象企業の例（全34件）

  • Abbexa Ltd.
  • Aviva Systems Biology Corporation
  • BioNote, Inc.
  • Bio-Rad Laboratories, Inc.
  • Creative Diagnostics
  • Demeditec Diagnostics GmbH
  • Express Biotech International Inc.
  • Merck KGaA
  • MyBioSource.com
  • Norgen Biotek Corp.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP22670

Global Rabies Diagnostics Market to Reach US$2.8 Billion by 2030

The global market for Rabies Diagnostics estimated at US$1.9 Billion in the year 2023, is expected to reach US$2.8 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2023-2030. Fluorescent Antibody Tests (FAT), one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$910.1 Million by the end of the analysis period. Growth in the Immunohistochemical Tests segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$512.7 Million While China is Forecast to Grow at 7.8% CAGR

The Rabies Diagnostics market in the U.S. is estimated at US$512.7 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$602.3 Million by the year 2030 trailing a CAGR of 7.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.4% and 4.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Rabies Diagnostics: Ensuring Timely Detection and Prevention of a Deadly Disease

What Are Rabies Diagnostics and Why Are They Critical in Public Health?

Rabies diagnostics refer to the methods and tools used to detect the rabies virus in animals and humans. Timely diagnosis is essential because rabies is nearly always fatal once symptoms appear, but it is preventable with prompt and effective treatment if identified early. Rabies diagnostics play a crucial role in public health by helping prevent outbreaks, guiding treatment decisions, and informing vaccination campaigns. Accurate diagnostic methods also aid veterinarians and wildlife professionals in identifying infected animals, allowing them to implement control measures to protect both human and animal populations. The disease, which is transmitted through saliva from an infected animal bite, affects the central nervous system and can spread to nearly any warm-blooded species, making effective diagnostics vital for controlling and preventing rabies transmission.

Early and precise rabies diagnostics are essential for assessing possible exposure in bite victims. If rabies is suspected, diagnostics help guide the decision to administer post-exposure prophylaxis (PEP), a life-saving vaccine treatment given before symptoms develop. Rabies testing is also crucial in wildlife and domestic animal control, as animals, particularly wild species like bats, raccoons, foxes, and stray dogs, are primary rabies carriers. Through accurate diagnostics, health authorities can implement surveillance programs, identify at-risk areas, and focus preventive efforts on regions with high incidence rates. These actions are critical in maintaining public health and safety, especially in areas where rabies remains endemic.

What Diagnostic Methods Are Commonly Used to Detect Rabies?

The gold standard for rabies diagnosis is the Direct Fluorescent Antibody (DFA) Test, which involves analyzing brain tissue from an animal postmortem. This test uses fluorescently labeled antibodies that bind to rabies virus antigens, allowing for direct visualization under a microscope. The DFA test is highly sensitive and specific, providing results in a short time frame, and remains the primary method for confirming rabies in animals. However, because it requires brain tissue, it is invasive and can only be performed after the animal's death, limiting its use to suspected cases in animals that have died or been euthanized.

For humans and in situations where non-invasive testing is preferred, several other diagnostic methods are used. Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) is a molecular technique that detects the presence of rabies virus RNA in samples like saliva, skin biopsies, and cerebrospinal fluid. RT-PCR can be performed on living patients, providing a way to detect rabies before death, though it is less sensitive than DFA and can yield false negatives, especially in early stages of infection. Enzyme-Linked Immunosorbent Assay (ELISA) and serological tests are also used to detect rabies antibodies in blood, though they are typically more useful for confirming previous exposure rather than diagnosing active infection. Combined, these methods enable a more comprehensive diagnostic approach, enhancing the ability to detect and respond to rabies in both animals and humans.

How Are Rabies Diagnostics Evolving with New Technology?

Recent advancements in rabies diagnostics focus on improving speed, accessibility, and non-invasive options for early detection. Rapid rabies diagnostic tests, often based on lateral flow assay technology, have been developed to provide quick, on-site testing results without the need for specialized laboratory equipment. These rapid tests are particularly useful in field settings, allowing veterinarians and health professionals to assess suspected cases quickly and implement quarantine or vaccination measures as needed. Although not as precise as the DFA test, these portable diagnostics offer a valuable tool for preliminary screening, especially in rural or resource-limited areas where access to laboratory facilities may be limited.

Innovations in molecular diagnostics, including real-time PCR and next-generation sequencing, are also enhancing rabies detection capabilities. Real-time PCR techniques can quantify viral load in samples, providing more sensitive detection even at lower viral levels, which is beneficial for early diagnosis in humans and animals. Additionally, research is ongoing into developing non-invasive diagnostic methods that use saliva or tears to detect rabies in living animals, which could potentially enable early detection in domestic pets and reduce the need for euthanasia in suspect cases. As diagnostic technology advances, the goal is to create more accessible, reliable, and humane rabies testing methods that improve disease management and prevention across diverse settings.

What Factors Are Driving the Growth in the Rabies Diagnostics Market?

The growth in the rabies diagnostics market is driven by factors such as increasing awareness of rabies prevention, advancements in diagnostic technologies, and the rising demand for accessible diagnostics in high-risk regions. As awareness grows around the dangers of rabies and the importance of early diagnosis, healthcare authorities and veterinary organizations are prioritizing rabies diagnostic testing to control and prevent outbreaks. Furthermore, rapid urbanization in many parts of the world has increased human-wildlife interactions, raising the potential for rabies exposure and the need for widespread diagnostic capabilities.

Technological advancements have also made rabies diagnostics more accessible, with portable rapid tests and molecular testing techniques now available for field and clinical use. These innovations address the challenges of testing in remote areas, particularly in regions of Africa, Asia, and Latin America, where rabies remains endemic. Additionally, government initiatives and collaborations with non-profit organizations to reduce rabies cases globally, such as the World Health Organization’s “Zero by 30” goal to eliminate human deaths from dog-mediated rabies by 2030, have created a supportive environment for rabies diagnostics development and deployment. These combined factors are driving growth in the rabies diagnostics market, supporting efforts to reduce rabies transmission and improve public health outcomes worldwide.

SCOPE OF STUDY:

The report analyzes the Rabies Diagnostics market in terms of US$ Thousand by the following Method; Technology, and Geographic Regions/Countries:

Segments:

Method (Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations, Serology Tests); Technology (ELISA / Immunohistochemistry, Chromatography, PCR, Other Technologies)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • Abbexa Ltd.
  • Aviva Systems Biology Corporation
  • BioNote, Inc.
  • Bio-Rad Laboratories, Inc.
  • Creative Diagnostics
  • Demeditec Diagnostics GmbH
  • Express Biotech International Inc.
  • Merck KGaA
  • MyBioSource.com
  • Norgen Biotek Corp.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Rabies Diagnostics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Rabies in Developing Regions Drives Demand for Advanced Rabies Diagnostic Solutions
    • Increased Focus on Zoonotic Disease Control and Prevention Spurs Growth in Rabies Diagnostics
    • Advancements in Rapid Diagnostic Techniques Enhance Accessibility and Accuracy of Rabies Testing
    • Growing Awareness Programs for Rabies Prevention and Early Detection Expand Market for Diagnostic Tools
    • Expansion of Veterinary Diagnostics for Rabies Testing in Domestic and Wild Animals Supports Market Growth
    • Technological Innovations in Point-of-Care (POC) Rabies Testing Boost Adoption in Remote and Low-Infrastructure Regions
    • Rising Adoption of Molecular Diagnostic Techniques Strengthens Accuracy and Sensitivity of Rabies Diagnostics
    • Growing Use of Immunohistochemistry (IHC) and ELISA Techniques in Rabies Diagnostics Expands Laboratory Testing Market
    • Increasing Prevalence of Rabies in Asia and Africa Spurs Demand for Field-Ready Diagnostic Tools
    • Rising Demand for Cost-Effective and User-Friendly Diagnostic Kits Expands Accessibility in Low-Resource Settings
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Rabies Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Rabies Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Rabies Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Fluorescent Antibody Tests (FAT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Fluorescent Antibody Tests (FAT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Fluorescent Antibody Tests (FAT) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Immunohistochemical Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Immunohistochemical Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Immunohistochemical Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Amplification Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Amplification Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Amplification Methods by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Histologic Examinations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Histologic Examinations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Histologic Examinations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Serology Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Serology Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Serology Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for ELISA / Immunohistochemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for ELISA / Immunohistochemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for ELISA / Immunohistochemistry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Chromatography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for PCR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 30: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 31: World Rabies Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Rabies Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • JAPAN
    • Rabies Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • CHINA
    • Rabies Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: China 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: China 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • EUROPE
    • Rabies Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Rabies Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Rabies Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Rabies Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • FRANCE
    • Rabies Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 65: France Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: France 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: France 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • GERMANY
    • Rabies Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Germany 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Italy 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Rabies Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 83: UK Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 86: UK Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: UK 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Spain 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Spain 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Russia 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Russia 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Rest of Europe 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Rest of Europe 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Rabies Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Rabies Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Rabies Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Rabies Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: Asia-Pacific 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Rabies Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: Australia 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: Australia 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • INDIA
    • Rabies Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 122: India Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: India 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 125: India Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: India 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: South Korea 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: South Korea 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Rabies Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Rabies Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Rabies Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Rabies Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Latin America 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Argentina 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Argentina 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Brazil 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Brazil 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Mexico 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Mexico 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Rest of Latin America 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: Rest of Latin America 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Rabies Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Rabies Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Rabies Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Rabies Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Middle East 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Iran 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Iran 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Israel 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: Israel 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: Saudi Arabia 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Saudi Arabia 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: UAE 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: UAE 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: Rest of Middle East 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 211: Rest of Middle East 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • AFRICA
    • Rabies Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 214: Africa 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 217: Africa 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030

IV. COMPETITION